Trial intelligence / Profile preview

High-dose vitamin D3 in critically ill adults with severe vitamin D deficiency

2016-002460-13Phase 3Active

Sponsor
Medical University of Graz
Start
Nov 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in critical illness and Vitamin D deficiency (VDD) comparing High-dose colecalciferol with Placebo (2 arms). Primary endpoint: 28-day mortality. Started Nov 2016; status: active.

02

Drugs

cholecalciferol
03

Conditions

critical illnessVitamin D deficiency (VDD)

Beyond the preview

Go deeper on 2016-002460-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-002460-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call